| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/20/2001 | US6203982 Dna of a 3' flanking region of synthase gene; drug screening; antitumor/anticarcinogenic agents; viricides; antiarthritic agents; antiischemic agents; prevention of restenosis; treatment of autoimmune disease |
| 03/20/2001 | US6203835 For promoting animal growth and improving feed utilization efficiency by an animal, and as antimicrobial component in animal feeds |
| 03/20/2001 | US6203823 Calcium taurate as a dietary supplement |
| 03/20/2001 | US6203813 Opiate antagonist, steroidal antiinflammatory agent and carrier; sustained release; drug abuse treatment |
| 03/20/2001 | US6203812 Polyurethane/poly(n-vinyl lactam) blend with microbiocide; easily removed |
| 03/20/2001 | US6203805 Topical compositions containing whey proteins |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | US6203797 Freeze dried aloe, vitamin b6 hydrochloride, manganes, glutamine, fructooligosaccharides and dahlia inulin juice |
| 03/20/2001 | US6203792 Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof |
| 03/20/2001 | US6203789 Treating erythrocytes with s-nitroso-cysteine, homocysteine, or cysteinylglycine to reduce blood pressure |
| 03/20/2001 | US6203785 Poly(diallylamine)-based bile acid sequestrants |
| 03/20/2001 | US6203783 Use of alkyl polyglycosides and/or of O-acylated derivatives of glucose for treating hair loss |
| 03/20/2001 | US6203782 Topically applying anole, anethole or polymers thereof and/or fenchone; remelanization |
| 03/20/2001 | CA2237979C Reduction of hair growth |
| 03/20/2001 | CA2206287C Aryl thioxanthines |
| 03/20/2001 | CA2199128C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 03/20/2001 | CA2180571C Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| 03/20/2001 | CA2180178C Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis |
| 03/20/2001 | CA2158399C Novel pharmaceutical product |
| 03/20/2001 | CA2132841C Aminocyclohexylamides for antiarrhythmic and anaesthetic uses |
| 03/20/2001 | CA2102429C Bone growth factors and inhibitors of bone resorption for promoting bone formation |
| 03/20/2001 | CA2071529C Diaromatic substituted anti-aids compounds |
| 03/20/2001 | CA2019798C Fucosidase inhibitors |
| 03/20/2001 | CA2007761C Novel benzo[b][1,8]naphtyridine derivatives and process for preparing the same |
| 03/20/2001 | CA2007760C Novel benzo[b][1,8]naphtyridine derivatives; process for preparing the same and compositions containing them |
| 03/16/2001 | CA2317257A1 4-amino-1-aryl-1,5-dihydropyrrol-2-ones having anticonvulsant and anxiolytic activity and processes for their preparation |
| 03/15/2001 | WO2001018546A2 Screening for inhibitors of 'paired helical filaments' |
| 03/15/2001 | WO2001018234A1 Method to identify gene function using small molecule probes |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018193A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | WO2001018181A2 Enzyme inhibitors |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018171A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 03/15/2001 | WO2001018161A2 Process for the preparation of conjugated linoleic acid (cla) |
| 03/15/2001 | WO2001018125A1 Synthetic vegetal melanins, process for their production and compositions containing thereof |
| 03/15/2001 | WO2001018091A1 Sulfonated comb polymers with selected lithium/sodium ratio and preparations, especially, hair-cosmetic preparations, on the basis of such sulfonated comb polymers |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018040A2 Use of leptin in inhibition of endothelial cell proliferation |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018029A1 Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis |
| 03/15/2001 | WO2001018028A1 Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds for inhibiting oestrone sulfatase |
| 03/15/2001 | WO2001018027A1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 03/15/2001 | WO2001018026A1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds |
| 03/15/2001 | WO2001018025A2 17alpha propynyl 11-aryl steroids |
| 03/15/2001 | WO2001018024A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 03/15/2001 | WO2001018023A1 Antisense modulation of pi3 kinase p110 beta expression |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018015A1 Oligonucleotide n3'→p5' thiophosphoramidates: their synthesis and use |
| 03/15/2001 | WO2001018013A1 Prodrugs for liver specific drug delivery |
| 03/15/2001 | WO2001018011A1 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 03/15/2001 | WO2001018006A1 Inhibitors of prenyl-protein transferase |
| 03/15/2001 | WO2001018004A2 PYRAZOLO[4,3-d]PYRIMIDINES |
| 03/15/2001 | WO2001018003A1 Carbocyclic nucleosides and process for obtaining such |
| 03/15/2001 | WO2001018001A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 03/15/2001 | WO2001018000A1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 03/15/2001 | WO2001017999A2 Amino-triazolopyridine derivatives |
| 03/15/2001 | WO2001017995A1 Tyrosine kinase inhibitors |
| 03/15/2001 | WO2001017994A1 Oxazole ppar antagonists |
| 03/15/2001 | WO2001017992A1 Inhibitors of prenyl-protein transferase |
| 03/15/2001 | WO2001017989A2 Heteroaryloxypropanolamines as beta3-adrenergic receptor agonists |
| 03/15/2001 | WO2001017988A1 Novel chalcones |
| 03/15/2001 | WO2001017986A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | WO2001017985A1 Novel derivatives of flavones, xanthones and coumarins |
| 03/15/2001 | WO2001017984A1 Chalcone coumarins |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | WO2001017981A1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors |
| 03/15/2001 | WO2001017976A1 Bis-sulfonamides |
| 03/15/2001 | WO2001017963A2 Aminoalkoxy carbazoles and their use as 5-ht ligands |
| 03/15/2001 | WO2001017959A2 Vitronectin receptor antagonists |
| 03/15/2001 | WO2001017956A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/15/2001 | WO2001017955A2 Hydroxyacetamidobenzenesulphonamide derivatives |
| 03/15/2001 | WO2001017954A1 Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same |
| 03/15/2001 | WO2001017953A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/15/2001 | WO2001017942A1 Amides as inhibitors for pyruvate dehydrogenase |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017596A1 Method of treating cardio pulmonary diseases with no group compounds |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017565A2 Polyoxyalkylenes conjugates as enzyme inhibitors |
| 03/15/2001 | WO2001017564A2 Enzyme inhibitors |
| 03/15/2001 | WO2001017563A2 Integrin-mediated drug targeting |
| 03/15/2001 | WO2001017562A1 Osteogenesis promoting agents |
| 03/15/2001 | WO2001017560A1 Method for treating and preventing bacterial infection |
| 03/15/2001 | WO2001017549A1 Stably storable oxygen transfusion |
| 03/15/2001 | WO2001017543A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 03/15/2001 | WO2001017541A1 Composition for extending post meal satiety |
| 03/15/2001 | WO2001017531A1 Promotion of wound healing |
| 03/15/2001 | WO2001017530A1 Iron chelators and uses thereof |
| 03/15/2001 | WO2001017528A1 Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
| 03/15/2001 | WO2001017527A1 Preventive and therapeutic agents for eye diseases |
| 03/15/2001 | WO2001017526A1 Treatment of skin disorders |
| 03/15/2001 | WO2001017525A1 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 03/15/2001 | WO2001017524A1 Methods for treating cell proliferative disorders including cancer |
| 03/15/2001 | WO2001017523A1 Compositions and methods for modification of skin lipid content |
| 03/15/2001 | WO2001017522A1 Method of treating cancer using tetraethyl thiuram disulfide |
| 03/15/2001 | WO2001017521A1 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
| 03/15/2001 | WO2001017520A1 New use for alpha receptor stimulating compounds |
| 03/15/2001 | WO2001017519A1 Sunscreen agent for oral administration |
| 03/15/2001 | WO2001017518A2 Method of treatment of influenza |
| 03/15/2001 | WO2001017517A2 Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer |